Compare FCEL & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCEL | BLFS |
|---|---|---|
| Founded | 1969 | 1987 |
| Country | United States | United States |
| Employees | 629 | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | 2013 |
| Metric | FCEL | BLFS |
|---|---|---|
| Price | $27.72 | $28.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $8.31 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 13.5M | 1.0M |
| Earning Date | 06-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | $4.77 | $19.73 |
| Revenue Next Year | $42.46 | $17.82 |
| P/E Ratio | ★ N/A | $1,405.50 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $3.78 | $17.86 |
| 52 Week High | $37.88 | $30.00 |
| Indicator | FCEL | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 58.00 | 61.64 |
| Support Level | $6.90 | $23.80 |
| Resistance Level | N/A | $28.90 |
| Average True Range (ATR) | 4.53 | 1.43 |
| MACD | 1.02 | 0.09 |
| Stochastic Oscillator | 55.00 | 63.90 |
FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.